Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Nat Med ; 6(4): 435-42, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10742151

RESUMEN

Here, we demonstrate a previously unknown function for the 70-kDa heat-shock protein (HSP70) as a cytokine. HSP70 bound with high affinity to the plasma membrane, elicited a rapid intracellular calcium flux, activated nuclear factor (NF)-kappaB and upregulated the expression of pro-inflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-6 in human monocytes. Furthermore, two different signal transduction pathways were activated by exogenous HSP70: one dependent on CD14 and intracellular calcium, which resulted in increased IL-1beta, IL-6 and TNF-alpha; and the other independent of CD14 but dependent on intracellular calcium, which resulted in an increase in TNF-alpha but not IL-1beta or IL-6. These findings indicate that CD14 is a co-receptor for HSP70-mediated signaling in human monocytes and are indicative of an previously unrecognized function for HSP70 as an extracellular protein with regulatory effects on human monocytes, having a dual role as chaperone and cytokine.


Asunto(s)
Proteínas HSP70 de Choque Térmico/inmunología , Proteínas I-kappa B , Interleucina-1/biosíntesis , Interleucina-6/biosíntesis , Factor de Necrosis Tumoral alfa/biosíntesis , Calcio/inmunología , Células Cultivadas , Citocinas/inmunología , Citocinas/fisiología , Proteínas de Unión al ADN/inmunología , Proteínas de Unión al ADN/metabolismo , Proteínas HSP70 de Choque Térmico/farmacología , Humanos , Receptores de Lipopolisacáridos/inmunología , Monocitos/citología , Monocitos/efectos de los fármacos , Monocitos/inmunología , Inhibidor NF-kappaB alfa , FN-kappa B/antagonistas & inhibidores , Células Tumorales Cultivadas
2.
Stress ; 12(3): 240-9, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-18850491

RESUMEN

We studied the physiological role of the 72 kDa extracellular heat shock protein (Hsp72, a stress-inducible protein) in modulating neutrophil chemotaxis during a single bout of intense exercise performed by sedentary women, together with various cell mechanisms potentially involved in the modulation. For each volunteer, we evaluated neutrophil chemotaxis and serum Hsp72 concentration before and immediately after a single bout of exercise (1 h on a cycle ergometer at 70% VO(2) max), and 24 h later. Both parameters were found to be stimulated by the exercise, and had returned to basal values 24 h later. In vitro, there was a dose-dependent increase in chemotaxis when neutrophils were incubated both with physiological Hsp72 concentrations and with a 100 x greater concentration. The chemotaxis was greater when the neutrophils were incubated with the post-exercise Hsp72 concentration than with the basal concentration, suggesting a physiological role for this protein in the context of the stimulation of neutrophil chemotaxis by intense exercise. The 100 x Hsp72 concentration stimulated chemotaxis even more strongly. In addition, Hsp72 was found to have chemoattractant and chemokinetic effects on the neutrophils at physiological concentrations, with these effects being significantly greater with the post-exercise than with the basal Hsp72 concentration. The Hsp72-induced stimulation of neutrophil chemotaxis disappeared when the toll-like receptor 2 (TLR-2) was blocked, and phosphatidylinositol-3-kinase (PI3K), extracellular signal-regulated kinase (ERK), and nuclear transcription factor kappa B (NF-kappaB) were also found to be involved in the signaling process. No changes were observed, however, in neutrophil intracellular calcium levels in response to Hsp72. In conclusion, physiological concentrations of the stress protein Hsp72 stimulate human neutrophil chemotaxis through TLR-2 with its cofactor CD14, involving ERK, NF-kappaB, and PI3K, but not iCa(2 + ), as intracellular messengers. In addition, Hsp72 seems to participate in the stimulation of chemotaxis induced by a single bout of intense exercise performed by sedentary women.


Asunto(s)
Quimiotaxis de Leucocito/fisiología , Proteínas del Choque Térmico HSP72/fisiología , Neutrófilos/fisiología , Esfuerzo Físico/fisiología , Calcio/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/fisiología , Femenino , Proteínas del Choque Térmico HSP72/sangre , Humanos , FN-kappa B/fisiología , Fosfatidilinositol 3-Quinasas/fisiología , Adulto Joven
3.
J Leukoc Biol ; 55(3): 392-7, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8120456

RESUMEN

We investigated effects of the biogenic diamine histamine on antibody-dependent cellular cytotoxicity (ADCC) against autologous anti-D-coated red blood cells mediated by human granulocytes, monocytes, and natural killer (NK) cells. Effector cells were separated from peripheral blood by countercurrent centrifugal elutriation. ADCC of monocytes and neutrophilic granulocytes was suppressed by histamine. ADCC of enriched CD3-/56+ NK cells was unchanged by histamine. ADCC of NK cells was effectively inhibited by elutriated monocytes or neutrophils. Histamine completely reversed the inhibition of NK cell-mediated ADCC induced by monocytes and partly reversed the inhibition induced by neutrophils; thereby, histamine augmented ADCC of NK cells in the presence of monocytes or neutrophils. The indirect effect of histamine on ADCC of NK cells and the effect of histamine on ADCC of monocytes/neutrophils were completely antagonized by the specific H2 receptor (H2R) blocker ranitidine. We conclude that activation of H2R suppresses ADCC reactivity of monocytes/neutrophils and, concomitantly, promotes ADCC reactivity of NK cells by abrogating a phagocyte-derived, suppressive signal.


Asunto(s)
Citotoxicidad Celular Dependiente de Anticuerpos/fisiología , Granulocitos/citología , Granulocitos/fisiología , Histamina/fisiología , Células Asesinas Naturales/citología , Células Asesinas Naturales/fisiología , Monocitos/citología , Monocitos/fisiología , Comunicación Celular , Células Cultivadas , Citometría de Flujo , Granulocitos/ultraestructura , Humanos , Células Asesinas Naturales/ultraestructura , Monocitos/ultraestructura , Ranitidina/farmacología , Receptores Histamínicos H2/análisis , Receptores Histamínicos H2/efectos de los fármacos , Receptores Histamínicos H2/fisiología
4.
Cell Stress Chaperones ; 5(5): 425-31, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11189447

RESUMEN

We recently elucidated a novel function for the 70-kDa heat shock protein (HSP70) as a chaperone and a cytokine, a chaperokine in human monocytes. Here we show that peptide-bearing and peptide-negative HSP70 preparations isolated from EMT6 mammary adenocarcinoma cells (EMT6-HSP70) act as chaperokines when admixed with murine splenocytes. EMT6-HSP70 bound with high affinity to the surface of splenocytes recovered from naive BALB/c mice. The [Ca2+]i inhibitor BAPTA dose dependently inhibited HSP70- but not LPS-induced NF-kappaB activity and subsequent augmentation of proinflammatory cytokine TNF-alpha, IL-1beta, and IL-6 production. Taken together, these results suggest that presence of peptide in the HSP70 preparation is not required for spontaneous activation of cells of the innate immune system.


Asunto(s)
Adenocarcinoma , Proteínas HSP70 de Choque Térmico/farmacocinética , Neoplasias Mamarias Experimentales , Chaperonas Moleculares/farmacocinética , Monocitos/metabolismo , Animales , Calcio/metabolismo , Quelantes/farmacología , Ácido Egtácico/análogos & derivados , Ácido Egtácico/farmacología , Femenino , Proteínas HSP70 de Choque Térmico/inmunología , Interleucina-1/metabolismo , Interleucina-6/metabolismo , Lipopolisacáridos/farmacología , Ratones , Ratones Endogámicos BALB C , Chaperonas Moleculares/inmunología , Monocitos/inmunología , FN-kappa B/metabolismo , Unión Proteica/efectos de los fármacos , Unión Proteica/inmunología , Transducción de Señal/inmunología , Bazo/citología , Bazo/inmunología , Bazo/metabolismo , Células Tumorales Cultivadas , Factor de Necrosis Tumoral alfa/metabolismo
5.
Cell Stress Chaperones ; 5(5): 406-11, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11189444

RESUMEN

Heat shock protein 70 (HSP70) is a molecular chaperone involved in protein folding and resistance to the deleterious effects of stress. Here we show that HSP70 suppresses transcription of c-fos, an early response gene that is a key component of the ubiquitous AP-1 transcription factor complex. HSP70 repressed Ras-induced c-fos transcription only in the presence of functional heat shock factor1 (HSF1). This suggests that HSP70 functions as a corepressor with HSF1 to inhibit c-fos gene transcription. Therefore, besides its known function in the stress response, HSP70 also has the property of a corepressor and combines with HSF1 to antagonize Fos expression and may thus impact multiple aspects of cell regulation.


Asunto(s)
Proteínas de Unión al ADN/genética , Genes fos/fisiología , Genes ras/fisiología , Proteínas HSP70 de Choque Térmico/genética , Activación Transcripcional/fisiología , Animales , Células CHO , Cricetinae , Proteínas de Unión al ADN/metabolismo , Expresión Génica/fisiología , Proteínas HSP70 de Choque Térmico/metabolismo , Factores de Transcripción del Choque Térmico , Técnicas In Vitro , Luciferasas/genética , Chaperonas Moleculares/metabolismo , Regiones Promotoras Genéticas/fisiología , Factores de Transcripción , Transfección
6.
Cell Stress Chaperones ; 5(5): 415-24, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11189446

RESUMEN

Variances, particularly single nucleotide polymorphisms (SNP), in the genomic sequence of individuals are the primary key to understanding gene function as it relates to differences in the susceptibility to disease, environmental influences, and therapy. In this report, the HSP70B' gene is the target sequence for mutation detection in biopsy samples from human prostate cancer patients undergoing combined hyperthermia and radiation therapy at the Dana-Farber Cancer Institute, using temperature-modulated heteroduplex analysis (TMHA). The underlying principles of TMHA for mutation detection using DHPLC technology are discussed. The procedures involved in amplicon design for mutation analysis by DHPLC are detailed. The melting behavior of the complete coding sequence of the target gene is characterized using WAVEMAKER software. Four overlapping amplicons, which span the complete coding region of the HSP70B' gene, amenable to mutation detection by DHPLC were identified based on the software-predicted melting profile of the target sequence. TMHA was performed on PCR products of individual amplicons of the HSP70B' gene on the WAVE Nucleic Acid Fragment Analysis System. The criteria for mutation calling by comparing wild-type and mutant chromatographic patterns are discussed.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Análisis Mutacional de ADN/métodos , Proteínas HSP70 de Choque Térmico/genética , Mutación Puntual , Neoplasias de la Próstata/genética , Análisis Heterodúplex/métodos , Humanos , Masculino , Desnaturalización de Ácido Nucleico , Polimorfismo de Nucleótido Simple , Neoplasias de la Próstata/diagnóstico , Programas Informáticos , Temperatura
7.
Cell Stress Chaperones ; 5(5): 432-7, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11189448

RESUMEN

Heat shock transcription factor 1(HSF1) activation is a multistep process. The conversion of a latent cytoplasmic form to a nuclear, DNA binding state appears to be activated by nonsteroidal anti-inflammatory drugs. In previous studies, we showed that HSF 1 is phosphorylated by the protein kinase RSK2 in vitro and that this effect is inhibited by nonsteroidal anti-inflammatory drugs at the concentration that leads to the activation of HSF1 in vivo (Stevenson et al 1999). In the present study, using cells from a patient with Coffin-Lowry syndrome (deficient in RSK2), we demonstrate that RSK2 slightly represses activation of HSF1 in vivo at 37 degrees C. In Coffin-Lowry syndrome cells, HSF1-HSE DNA binding activity after treatment with sodium salicylate was slightly higher than that in untreated cells, indicating that although RSK2 is involved in HSF1 regulation, it is not the unique protein kinase that suppresses HSF1-HSE binding activity at 37 degrees C. However, heat shock treatment resulted in significantly higher HSF1-HSE binding activity in Coffin-Lowry syndrome cells as compared with normal controls, suggesting that RSK2 represses HSF1-HSE binding activity during heat shock.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Respuesta al Choque Térmico/fisiología , Proteínas Quinasas S6 Ribosómicas/farmacología , Antiinflamatorios no Esteroideos/farmacología , Niño , Proteínas de Unión al ADN/genética , Regulación Enzimológica de la Expresión Génica , Células HeLa , Factores de Transcripción del Choque Térmico , Respuesta al Choque Térmico/efectos de los fármacos , Humanos , Discapacidad Intelectual/genética , Linfocitos/citología , Linfocitos/enzimología , Masculino , Fosforilación , Unión Proteica/efectos de los fármacos , Unión Proteica/fisiología , Proteínas Quinasas S6 Ribosómicas/genética , Proteínas Quinasas S6 Ribosómicas/metabolismo , Salicilato de Sodio/farmacología , Factores de Transcripción , Transfección
8.
J Appl Physiol (1985) ; 80(5): 1799-803, 1996 May.
Artículo en Inglés | MEDLINE | ID: mdl-8727569

RESUMEN

The effect of chronic voluntary exercise on the immune response was studied in spontaneously hypertensive rats. Exercise consisted of voluntary running in wheels for 5 wk, and the mean running distance was 4.2 km/24 h. In vivo cytotoxicity was measured as clearance of injected 51Cr-labeled YAC-1 lymphoma cells from the lungs. The clearance of YAC-1 cells in vivo was significantly increased in runners compared with sedentary controls (P < 0.001). The total number of mononuclear cells in the spleen was significantly decreased in runners compared with controls. Analysis of splenic lymphocyte phenotypes revealed a significantly increased fraction of OX52+/CD5- natural killer cells in runners compared with sedentary controls. In contrast to changes in natural immunity, immunoglobulins G and M levels in serum, the antibody response to antigen in vivo, and the proliferation of splenic T cells in vitro were unchanged. Our data suggest that chronic voluntary exercise augments natural cytotoxicity mechanisms in vivo, whereas splenic T-cell proliferation and the antibody-mediated immune response remain unchanged.


Asunto(s)
Inmunoglobulina G/metabolismo , Inmunoglobulina M/metabolismo , Linfoma/metabolismo , Actividad Motora/fisiología , Animales , Condicionamiento Físico Animal , Ratas , Ratas Endogámicas SHR , Bazo/metabolismo
9.
Regul Pept ; 62(2-3): 113-8, 1996 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-8795073

RESUMEN

We have studied the effect of chronic intracerebroventricular (i.c.v.) infusion of different opioid peptides on natural killer (NK) cell mediated cytotoxicity in vivo in the spontaneously hypertensive rat (SHR). The in vivo NK cell activity was measured as the clearance of 51Cr-labelled YAC-l lymphoma cells from the lung tissues. Further, the phenotype of lymphocytes in spleen and peripheral blood was analysed by flow cytometry (FACS). All opioid drugs were administered i.c.v. for 6 days with osmotic minipumps releasing 1.0 microliter/h. beta-Endorphin (10 or 20 micrograms/rat per day) significantly increased NK cell cytotoxicity in vivo. The opioid receptor antagonist naloxone (10 mg/kg, i.p.) given immediately before the injection of YAC-lymphoma cells, completely abolished the effects of i.c.v. administered beta-endorphin. Corresponding doses of beta-endorphin administered subcutaneously (s.c.) with minipumps for 6 days did not significantly affect NK cell cytotoxicity. Neither Leu- or Met-enkephalin (20 micrograms/rat per day) nor dynorphin (20 micrograms/rat per day) administered i.c.v. had any significant effects on NK cell activity. In beta-endorphin treated SHR, the percentage of cells with NK cell phenotype (OX52+/CD5-) in peripheral blood was not significantly different from that of controls, while the percentage of cells with T cell phenotype (CD5+/OX52-) was significantly decreased. The percentage of splenic NK cells (OX52+/CD5-) and T cells (CD5+/OX52-) was also unchanged by beta-endorphin treatment i.c.v. These results suggest that of the opioid peptides administered i.c.v., only beta-endorphin augments in vivo NK cell mediated cytotoxicity. We thus conclude that these effects most probably are centrally and opioid receptor mediated effects, since beta-endorphin in the same dose administered peripherally does not influence in vivo NK cell cytotoxicity.


Asunto(s)
Citotoxicidad Inmunológica/efectos de los fármacos , Células Asesinas Naturales/inmunología , Activación de Linfocitos/efectos de los fármacos , betaendorfina/administración & dosificación , Administración Cutánea , Animales , Dinorfinas/administración & dosificación , Encefalinas/administración & dosificación , Inyecciones Intraventriculares , Linfoma/inmunología , Linfoma/patología , Masculino , Ratas , Ratas Endogámicas SHR , Células Tumorales Cultivadas
10.
Life Sci ; 58(23): 2137-46, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8649198

RESUMEN

We have previously shown that voluntary running for 4-5 weeks in the spontaneously hypertensive rat (SHR) significantly increased in natural cytotoxic mechanism in vivo, measured as clearance of 51Cr YAC-1 lymphoma cells from the lungs. In the present study, we have studied the possible role of the spleen and the splenic nerves in this augmentation. The SHR were randomly allocated to either a voluntary exercise group or a sedentary control group. After four weeks of exercise the runners and sedentary control SHR were further assigned to one of four groups: 1) no surgery, 2) sham operation, 3) splenic nerve section and 4) splenectomy. Splenectomy drastically reduced in vivo cytotoxicity in both runners and sedentary controls, but in vivo cytotoxicity of splenectomized voluntary runners was significantly higher than that of splenectomized sedentary control animals. Selective denervation of the spleen did not affect the in vivo cytotoxicity. These results indicate that the enhanced in vivo natural cytotoxic mechanism following voluntary chronic exercise in SHR is partly dependent on intact splenic function. However, this enhancement does not seem to be mediated by the splenic sympathetic nerves.


Asunto(s)
Inmunidad Innata , Esfuerzo Físico , Bazo/inervación , Bazo/fisiología , Animales , Citotoxicidad Inmunológica , Inmunidad Celular , Norepinefrina/metabolismo , Ratas , Ratas Endogámicas SHR
11.
Int J Mol Med ; 6(6): 705-10, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11078832

RESUMEN

HSF-1 is regulated at multiple molecular levels through intra- and intermolecular protein-protein interactions as well as by post-translational modification through phosphorylation. We have found that elevating intracellular calcium ion levels by exposure to the ionophore A23187 or thapsigargin inhibits the conversion of HSF-1 from a latent cytoplasmic form to its nuclear/DNA binding form. To examine a role for calcium/calmodulin regulated enzymes in this process, we examined the ability of specific inhibitors to abrogate the effects of calcium elevation. While the inhibitor of calmodulin dependent kinase II, KCN62 enhanced activation of HSF-1 during heat shock, it failed to block the inhibitory effects of calcium increase. By contrast, the immunosuppresant drugs cyclosporin A and FK506 abolished the effects of calcium elevation on HSF-1 activation. As the biological effects of the drugs are effected through inhibition of the calcium/calmodulin regulated phosphatase calcineurin, this suggests a role for calcineurin in antagonizing HSF-1 activity. The experiments suggest the existence of phosphorylated residue(s) in HSF-1 important in one or more of the processes that lead to activation (trimerization, nuclear localization, DNA binding) and which becomes dephosphorylated due to the activation of a calcium/calmodulin/calcineurin complex.


Asunto(s)
Calcio/fisiología , Proteínas de Unión al ADN/metabolismo , Fosfoproteínas Fosfatasas/metabolismo , Proteínas Quinasas/metabolismo , Calcimicina/farmacología , Calcineurina/metabolismo , Inhibidores de la Calcineurina , Calcio/metabolismo , Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina , Proteínas Quinasas Dependientes de Calcio-Calmodulina/antagonistas & inhibidores , Ciclosporina/farmacología , Proteínas de Unión al ADN/efectos de los fármacos , Proteínas de Unión al ADN/genética , Inhibidores Enzimáticos/farmacología , Factores de Transcripción del Choque Térmico , Humanos , Inmunosupresores/farmacología , Luciferasas/genética , Luciferasas/metabolismo , Fosfoproteínas Fosfatasas/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas , Proteínas Recombinantes de Fusión/efectos de los fármacos , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Tacrolimus/farmacología , Tapsigargina/farmacología , Factores de Transcripción , Células Tumorales Cultivadas , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismo
12.
Anticancer Res ; 17(5A): 3403-7, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9413179

RESUMEN

This study was undertaken to determine whether NK-cells constitute a necessary mediator for the suppression of tumor growth by indomethacin. C57Bl mice with a methylcholantrene (MCG 101) tumor were studied. Indomethacin treatment was provided by daily subcutaneous injections (1 microgram/g body weight). NK-cells were depleted by treatment with a monoclonal antibody to NK1.1. Consecutive indomethacin injections prolonged survival in tumor bearing animals. Indomethacin was equally effective in animals with intact NK-cells as in NK-cell-depleted animals. Further, the MCG cells were apparently insensitive to the lytic activity of NK-cells in vivo. Thus, the clearance of intravenously injected MCG cells from lungs was not affected by depletion of NK-cells in vivo; in contrast, the corresponding clearance of NK-cell-sensitive YAC-1 lymphoma cells was strikingly reduced by the depletion of NK-cells. Our data suggest that NK cells are not a necessary mediator for the suppression of tumor growth by indomethacin.


Asunto(s)
Antineoplásicos/farmacología , Indometacina/farmacología , Células Asesinas Naturales/fisiología , Sarcoma Experimental/tratamiento farmacológico , Animales , Citotoxicidad Inmunológica , Femenino , Depleción Linfocítica , Linfoma/tratamiento farmacológico , Ratones , Ratones Endogámicos C57BL , Sarcoma Experimental/inmunología
13.
ISRN Oncol ; 2013: 463594, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23936673

RESUMEN

Introduction. Breast cancer is the commonest cancer among women globally. In Uganda, it is on the rise, projected at a 4.5% annual ASR increase (age standardized incidence rate). The reasons for this steep increase are not fully established. In the recent past, gene profiling in tumor tissues suggests that breast cancers are divided into subtypes dependent on the presence or absence of oestrogen receptor, progesterone, and human epidermal growth factor receptor 2 (HER 2). These subtypes do have distinctive clinical outcomes and perhaps risk factors from past studies. There is paucity of data on hormonal receptor status and the traditionally known risk factors in sub-Saharan Africa. The purpose of this study therefore was to establish the differences between ER status and the traditionally known risk factors for breast cancer in Uganda. Methods. An observational analytical hospital, based study, carried out at Makerere University, College of Health Sciences. Formalin fixed and paraffin imbedded sections were prepared for haemotoxylin and eosin (H&E) stains and immunohistochemistry (IHC). Ethical approval was obtained. Results. A total of 113 women were recruited. Mean age was 45 years (SD14). There were no significant differences in selected risk factors (setting, age, contraceptive use, parity, breast feeding, or menarche) by ER status although ER negative tumors had significantly higher grade tumors (by a factor of two) compared to ER positive tumors. Conclusion. There were no significant differences among risk factors by ER status contrary to what several other studies suggest. The manifestation of breast cancer in Africa warrants further extensive inquiry.

14.
Curr Mol Med ; 12(9): 1142-50, 2012 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-22804237

RESUMEN

Heat shock proteins (HSP) are a group of physiologically-essential, highly-conserved proteins that are induced by heat shock, as well as by other environmental and pathophysiological stressors. The twentyseven kDa heat shock protein (Hsp27; HspB1) is highly expressed in tumor tissues of patients diagnosed with cancer and expression levels correlate with poor prognosis. HspB1 plays a dual role in cancer and promotes both cancer development by suppressing host anti-cancer response, such as apoptosis and senescence, and facilitates the enhanced expression of metastastic genes. HspB1-mediated protection from tumor cell apoptosis induced by chemotherapeutic drugs occurs through several mechanisms, including decreased production of reactive oxygen species, restoration of protein homeostasis and promotion of cell survival by protein folding, stabilization of actin-cytoskeleton, delayed release of cytochrome c from mitochondria and inhibition of activation of caspase-3. High levels of HSP expression affect tumor susceptibility to adjuvant cancer treatments, including chemotherapy, hyperthermia, and radiation. This review highlights the most recent findings and role of HspB1 in metastasis.


Asunto(s)
Proteínas de Choque Térmico HSP27/metabolismo , Proteínas de Choque Térmico/metabolismo , Metástasis de la Neoplasia/patología , Proteínas de Neoplasias/metabolismo , Envejecimiento/metabolismo , Animales , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Apoptosis , Supervivencia Celular , Humanos , Ratones , Chaperonas Moleculares , Pliegue de Proteína , Especies Reactivas de Oxígeno/metabolismo
15.
Interdiscip Perspect Infect Dis ; 2010: 254159, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20300577

RESUMEN

Enteroaggregative Escherichia coli (EAEC) are quite heterogeneous category of an emerging enteric pathogen associated with cases of acute or persistent diarrhea worldwide in children and adults, and over the past decade has received increasing attention as a cause of watery diarrhea, which is often persistent. EAEC infection is an important cause of diarrhea in outbreak and non-outbreak settings in developing and developed countries. Recently, EAEC has been implicated in the development of irritable bowel syndrome, but this remains to be confirmed. EAEC is defined as a diarrheal pathogen based on its characteristic aggregative adherence (AA) to HEp-2 cells in culture and its biofilm formation on the intestinal mucosa with a "stacked-brick" adherence phenotype, which is related to the presence of a 60 MDa plasmid (pAA). At the molecular level, strains demonstrating the aggregative phenotype are quite heterogeneous; several virulence factors are detected by polymerase chain reaction; however, none exhibited 100% specificity. Although several studies have identified specific virulence factor(s) unique to EAEC, the mechanism by which EAEC exerts its pathogenesis is, thus, far unknown. The present review updates the current knowledge on the epidemiology, chronic complications, detection, virulence factors, and treatment of EAEC, an emerging enteric food borne pathogen.

16.
Int J Hyperthermia ; 18(6): 597-608, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12537758

RESUMEN

Thermal therapy has been shown to be an extremely powerful anti-cancer agent and a potent radiation sensitizer. However, the full potential of thermal therapy is hindered by a number of considerations including highly conserved heat resistance pathways in tumour cells and inhomogeneous heating of deep-seated tumours due to energy deposition and perfusion issues. This report reviews recent progress in the development of hyperthermia sensitizing drugs designed to specifically amplify the effects of hyperthermia. Such agents might be particularly useful in situations where heating is not adequate for the full biological effect or is not homogeneously delivered to tumours. The particular pathway concentrated on is thermotolerance, a complex, inducible cellular response that leads to heat resistance. This paper will concentrate on the molecular pathways of thermotolerance induction for designing inhibitors of heat resistance/thermal sensitizers, which may allow the full potential of thermal therapy to be utilized.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Proteínas HSP70 de Choque Térmico/inmunología , Hipertermia Inducida , Neoplasias de la Próstata/tratamiento farmacológico , Animales , Supervivencia Celular , Terapia Combinada , Humanos , Masculino , Neoplasias de la Próstata/inmunología
17.
Immunology ; 93(2): 296-305, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9616382

RESUMEN

In vivo inoculation of specific antibody is an accepted protocol for elimination of specific cell populations. Except for anti-CD3 and anti-CD4, it is not known if the depleted cells are eliminated by signalling through the target molecule or through a more non-specific mechanism. C57BL/6 mice were inoculated with anti-natural killer (NK1.1) monoclonal antibody (mAb). Thereafter spleen cells were harvested, stained for both surface and intracellular markers, and analysed by flow cytometry. As early as 2 hr post inoculation, NK cells were signalled to become apoptotic while signalling through the NK1.1 molecule activated NK1.1+ T-cell receptor (TCR)+ (NK T) cells to increase in number, and produce interleukin-4 (IL-4). Anti NK1.1 mAb was less efficient at signalling apoptosis in NK cells when NK T-cell deficient [beta 2-microglobulin beta 2m-deficient] mice were used compared with wild type mice. Efficient apoptotic signalling was restored when beta 2m-deficient mice were reconstituted with NK T cells. NK-specific antibody best signals the apoptotic process in susceptible NK cells when resistant NK T cells are present, activated, and secrete IL-4.


Asunto(s)
Antígenos/inmunología , Apoptosis/inmunología , Interleucina-4/biosíntesis , Células Asesinas Naturales/inmunología , Proteínas/inmunología , Transducción de Señal/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Antígenos Ly , Antígenos de Superficie , Femenino , Lectinas Tipo C , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Subfamilia B de Receptores Similares a Lectina de Células NK , Bazo/inmunología
18.
J Immunol ; 145(12): 4365-70, 1990 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-2147942

RESUMEN

The formation of lung metastases by i.v.-injected B16 melanoma (F1 and F10 strain) cells in Swiss albino, C57BL/6, and BALB/c mice was reduced by a single dose of histamine given 24 h before tumor cell inoculation. The antimetastatic effect of histamine was specifically mediated by histamine H2-receptors (H2R): it was blocked by the H2R antagonist ranitidine and mimicked by dimaprit, a specific H2R agonist but not by an H2R-inactive structural analog of this compound, nor-dimaprit, or the H1R agonist 2-thiazolyl-ethylamide. A single dose of any of the H2R antagonists ranitidine, tiotidine, famotidine, or cimetidine drastically augmented metastasis. Effects of H2R-interactive compounds on B16 metastasis required intact NK cells, as judged by the inability of histamine or ranitidine to affect B16 metastasis after NK cell depletion in vivo using antibodies to asialo-GM1. NK-cell-mediated lysis of YAC-1 lymphoma cells in vivo was enhanced by histamine and reduced by ranitidine within 4 h after inoculation of tumor cells. The antimetastatic effect of IL-2 was potentiated by histamine; in some experiments, combined treatment with a low dose of IL-2 (6000 U/kg) and histamine completely eliminated metastasis, whereas concomitant treatment with ranitidine abrogated antimetastatic effects of IL-2; animals treated with ranitidine and IL-2 displayed the same level of enhanced metastasis as those treated with ranitidine alone. The presented data are suggestive of an earlier unrecognized role for histamine in NK cell-mediated resistance against metastatic tumor cells.


Asunto(s)
Histamina/fisiología , Células Asesinas Naturales/inmunología , Neoplasias Experimentales/inmunología , Animales , Citotoxicidad Inmunológica , Dimaprit , Inmunidad Celular , Interleucina-2/farmacología , Neoplasias Pulmonares/secundario , Melanoma Experimental/patología , Ratones , Ratones Endogámicos , Metástasis de la Neoplasia , Ranitidina/farmacología , Receptores Histamínicos H2/fisiología , Tiourea/farmacología
19.
Clin Diagn Lab Immunol ; 2(3): 277-80, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7664171

RESUMEN

Depletion of natural killer (NK) cells in vivo with anti-NK1.1 monoclonal antibody or anti-asialo-GM1 antiserum drastically reduced survival time in Swiss albino mice infected intravenously (i.v.) with herpes simplex virus type 2 (HSV-2). In contrast, depletion of NK cells did not affect the survival time of mice inoculated with HSV-2 by the intraperitoneal route. A single dose of histamine prolonged survival time in animals inoculated with HSV-2 i.v. but not in animals infected intraperitoneally. Treatment with the histamine H2 receptor antagonist ranitidine alone reduced survival time in i.v.-infected animals and blocked the protective effect of histamine. Histamine or ranitidine did not affect survival time in anti-NK1.1- or anti-asialo-GM1-treated animals. Our data suggest a role for histaminergic mechanisms in NK cell-mediated protection against HSV-2.


Asunto(s)
Encefalitis/virología , Herpes Simple , Herpesvirus Humano 2/inmunología , Histamina/fisiología , Células Asesinas Naturales/inmunología , Animales , Vías de Administración de Medicamentos , Sinergismo Farmacológico , Encefalitis/tratamiento farmacológico , Encefalitis/inmunología , Femenino , Herpesvirus Humano 2/efectos de los fármacos , Histamina/inmunología , Histamina/farmacología , Interleucina-2/inmunología , Interleucina-2/farmacología , Células Asesinas Naturales/virología , Ratones , Ranitidina/farmacología , Análisis de Supervivencia , Factores de Tiempo
20.
Scand J Immunol ; 43(1): 9-15, 1996 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8560202

RESUMEN

Treatment of Swiss albino mice with histamine enhanced the clearance of natural killer (NK)-cell sensitive YAC-1 lymphoma and B16/F10 melanoma cells from lung tissue in vivo, but did not affect the elimination of NK-cell-insensitive P815 mastocytoma cells. The effect of histamine was apparently mediated by H2-type histamine receptors (H2R) since it was blocked by ranitidine, and H2R antagonist. Histamine did not affect clearance of tumour cells in animals depleted of NK cells in vivo by treatment with antibodies to asialo-GM1 or NK1.1. The effect of histamine was time-dependent: pretreatment with histamine for 3 h significantly augmented the clearance of YAC-1 cells, whereas, pretreatment with histamine for 5 min was ineffective. Histamine potentiated the anti-tumour properties of NK-cell activators such as interleukin-2 (IL-2) or interferon-alpha (IFN-alpha) in vivo. None of these lymphokines significantly affected the clearance of YAC-1 cells unless animals were concomitantly treated with histamine. Treatment with ranitidine alone reduced the in vivo clearance of YAC-1 cells from lungs but did not affect the clearance of NK-cell-insensitive P815 cells. Effects of ranitidine on NK-cell function in vivo were not shared by a chemical control to ranitidine, AH20239AA, thus indicating that the inhibition of NK-cells results from H2R antagonism rather than non-specific toxicity. It is concluded that histaminergic mechanisms may be involved in the regulation of NK cell function in vivo.


Asunto(s)
Histamina/farmacología , Células Asesinas Naturales/fisiología , Neoplasias Pulmonares/fisiopatología , Linfoma/fisiopatología , Melanoma Experimental/fisiopatología , Animales , Anticuerpos/farmacología , Citotoxicidad Inmunológica/efectos de los fármacos , Femenino , Gangliósido G(M1)/inmunología , Antagonistas de los Receptores H2 de la Histamina/farmacología , Inmunidad Celular , Interferón-alfa/farmacología , Interleucina-2/farmacología , Células Asesinas Naturales/efectos de los fármacos , Neoplasias Pulmonares/inmunología , Linfoma/inmunología , Melanoma Experimental/inmunología , Ratones , Ranitidina/análogos & derivados , Ranitidina/farmacología , Receptores Histamínicos H2/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA